• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Shiladitya Sengupta

Publications

  • Sengupta S, Kulkarni A.Design principles for clinical efficacy of cancer nanomedicine: a look into the basics.ACS Nano. 2013 Apr 23;7(4):2878-82.
    23607425
  • Sarangi S, Pandey A, Papa AL, Sengupta P, Kopparam J, Dadwal U, Basu S, Sengupta S.P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.Med Oncol. 2013 Jun;30(2):567.
    23568163
  • Papa AL, Basu S, Sengupta P, Banerjee D, Sengupta S, Harfouche R.Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.BMC Cancer. 2012 Sep 22;12(1):419.
    22998550
  • Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S.Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11294-9.
    22733767
  • Banerjee D, Harfouche R, Sengupta S.Nanotechnology-mediated targeting of tumor angiogenesis.Vascular Cell. 2011;3(1):3.
    21349160
  • Sengupta P, Basu S, Sengupta S.Cancer, Signal Transduction and Nanotechnology.Current Drug Delivery. 2011 Feb 3.
    21291374
  • Piecewicz S, Sengupta S.The Dynamic Glycome Microenvironment and Stem Cell Differentiation into Vasculature.Stem Cells Dev. 2011 Jan 4.
    21091341
  • Sinha Roy R, Soni S, Harfouche R, Vasudevan PR, Holmes O, de Jonge H, Rowe A, Paraskar A, Hentschel DM, Chirgadze D, Blundell TL, Gherardi E, Mashelkar RA, Sengupta S.Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis.Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13608-13.
    20639469
  • Paraskar AS, Soni S, Chin KT, Chaudhuri P, Muto KW, Berkowitz J, Handlogten MW, Alves NJ, Bilgicer B, Dinulescu DM, Mashelkar RA, Sengupta S.Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy.Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12435-40.
    20616005
  • Agarwal S, Dugar D, Sengupta S.Ranking chemical structures for drug discovery: a new machine learning approach.J Chem Inf Model. 2010 May 24;50(5):716-31.
    20387860
  • Chaudhuri P, Harfouche R, Soni S, Hentschel DM, Sengupta S.Shape effect of carbon nanovectors on angiogenesis.ACS Nano. 2010 Jan 26;4(1):574-82.
    20043662
  • Chaudhuri P, Soni S, Sengupta S.Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma.Nanotechnology. 2010 Jan 15;21(2):025102.
    19955607
  • Harfouche R, Hentschel DM, Piecewicz S, Basu S, Print C, Eavarone D, Kiziltepe T, Sasisekharan R, Sengupta S.Glycome and transcriptome regulation of vasculogenesis.Circulation. 2009 Nov 10;120(19):1883-92.
    19858418
  • Basu S, Chaudhuri P, Sengupta S.Targeting oncogenic signaling pathways by exploiting nanotechnology.Cell Cycle. 2009 Nov 1;8(21):3480-7. Review.
    19823014
  • Bocangel D, Sengupta S, Mitra S, Bhakat KK.p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor.Anticancer Res. 2009 Oct;29(10):3741-50.
    19846904
  • Chaudhuri P, Paraskar A, Soni S, Mashelkar RA, Sengupta S.Fullerenol-cytotoxic conjugates for cancer chemotherapy.ACS Nano. 2009 Sep 22;3(9):2505-14.
    19681636
  • Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S.Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. .Proc Natl Acad Sci U S A. May 12;106(19):7957-61.